Bioavailability of a commercial sustained-release quinidine tablet compared to oral quinidine solution. 1982

W T Sawyer, and C C Pulliam, and A Mattocks, and J Foster, and B W Hadzija, and H M Rosenthal

The bioavailability of quinidine sulfate after oral administration of a commercial sustained-release quinidine tablet was compared with that of oral quinidine sulfate solution in 18 normal subjects. Three hundred milligrams of each product was administered to each subject in standard cross-over fashion on separate occasions, with plasma quinidine levels measured for 46 h after each dose. Although peak plasma quinidine levels were lower, and occurred later, after tablet administration than after solution, analysis of the area under the plasma quinidine level-time curve (AUC) values for each product indicated that the products were equivalent, in terms of the extent of absorption, with the mean AUC (0-46 h) value for the tablet, 8744 . 4 ng x h ml-1, comparable to that of the solution, 9145 . 9 ng x h ml-1.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D011802 Quinidine An optical isomer of quinine, extracted from the bark of the CHINCHONA tree and similar plant species. This alkaloid dampens the excitability of cardiac and skeletal muscles by blocking sodium and potassium currents across cellular membranes. It prolongs cellular ACTION POTENTIALS, and decreases automaticity. Quinidine also blocks muscarinic and alpha-adrenergic neurotransmission. Adaquin,Apo-Quinidine,Chinidin,Quincardine,Quinidex,Quinidine Sulfate,Quinora,Apo Quinidine,Sulfate, Quinidine
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

W T Sawyer, and C C Pulliam, and A Mattocks, and J Foster, and B W Hadzija, and H M Rosenthal
January 1982, Clinical pharmacy,
W T Sawyer, and C C Pulliam, and A Mattocks, and J Foster, and B W Hadzija, and H M Rosenthal
October 1978, Journal of pharmaceutical sciences,
W T Sawyer, and C C Pulliam, and A Mattocks, and J Foster, and B W Hadzija, and H M Rosenthal
January 1990, Biopharmaceutics & drug disposition,
W T Sawyer, and C C Pulliam, and A Mattocks, and J Foster, and B W Hadzija, and H M Rosenthal
November 1987, Arerugi = [Allergy],
W T Sawyer, and C C Pulliam, and A Mattocks, and J Foster, and B W Hadzija, and H M Rosenthal
October 1974, Clinical pharmacology and therapeutics,
W T Sawyer, and C C Pulliam, and A Mattocks, and J Foster, and B W Hadzija, and H M Rosenthal
January 1983, Clinical therapeutics,
W T Sawyer, and C C Pulliam, and A Mattocks, and J Foster, and B W Hadzija, and H M Rosenthal
August 1979, European journal of clinical pharmacology,
W T Sawyer, and C C Pulliam, and A Mattocks, and J Foster, and B W Hadzija, and H M Rosenthal
August 1987, Clinical pharmacokinetics,
W T Sawyer, and C C Pulliam, and A Mattocks, and J Foster, and B W Hadzija, and H M Rosenthal
April 1986, International journal of clinical pharmacology, therapy, and toxicology,
W T Sawyer, and C C Pulliam, and A Mattocks, and J Foster, and B W Hadzija, and H M Rosenthal
August 2004, The Medical journal of Malaysia,
Copied contents to your clipboard!